Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 11:33 am Purchase | 2026-03-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Armistice Capital, LLC | 1,280,000 6.930% | 556,000 (+76.80%) | Filing History |
| 2026-05-07 5:01 pm Purchase | 2026-05-06 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 968,108 5.200% | 309,963 (+47.10%) | Filing History |
| 2026-03-27 11:38 am Sale | 2026-03-13 | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 0 0.000% | -895,322 (Position Closed) | Filing History |
| 2026-02-09 08:02 am Purchase | 2025-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 1,091,223 6.000% | 753,732 (+223.33%) | Filing History |
| 2025-11-14 6:22 pm Sale | 2025-09-30 | 13G | MACKENZIE RLTY CAP INC MKZR | Armistice Capital, LLC | 724,000 3.990% | -876,000 (-54.75%) | Filing History |
| 2025-10-07 4:15 pm Sale | 2025-09-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Morgan Stanley MS | 116,406 0.700% | -1,332,654 (-91.97%) | Filing History |
| 2025-08-14 9:31 pm Purchase | 2025-06-30 | 13G | MACKENZIE RLTY CAP INC MKZR | Armistice Capital, LLC | 1,600,000 8.920% | 84,000 (+5.54%) | Filing History |
| 2025-08-05 5:00 pm Sale | 2025-06-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 658,145 3.700% | -472,534 (-41.79%) | Filing History |
| 2025-05-15 3:46 pm Purchase | 2025-03-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Armistice Capital, LLC | 1,516,000 8.480% | 364,000 (+31.60%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 1,381,983 7.700% | -366,124 (-20.94%) | Filing History |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Armistice Capital, LLC | 1,152,000 6.540% | -384,000 (-25.00%) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 1,130,679 6.400% | 195,891 (+20.96%) | Filing History |
| 2025-02-07 1:42 pm Sale | 2024-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Invesco Ltd. IVZ | 6,449 0.000% | -1,044,906 (-99.39%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 1,748,107 9.900% | 228,299 (+15.02%) | Filing History |
| 2024-11-14 5:18 pm Sale | 2024-09-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Armistice Capital, LLC | 1,536,000 8.730% | -174,000 (-10.18%) | Filing History |
| 2024-11-14 3:33 pm Sale | 2024-09-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 934,788 5.300% | -9,470 (-1.00%) | Filing History |
| 2024-11-08 09:33 am Purchase | 2024-11-08 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Invesco Ltd. IVZ | 1,051,355 6.000% | 1,051,355 (New Position) | Filing History |
| 2024-02-14 2:30 pm Purchase | 2023-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Armistice Capital, LLC | 1,710,000 9.810% | 14,400 (+0.85%) | Filing History |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 895,322 5.130% | -313,058 (-25.91%) | Filing History |
| 2024-02-09 12:17 pm Purchase | 2023-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Morgan Stanley MS | 1,449,060 8.300% | 1,449,060 (New Position) | Filing History |